Abstract
The angiograms of 89 patients were reviewed from the LATE Ancillary Study (randomized trial of recombinant tissue plasminogen activator vs placebo in patients with symptom onset after 6 hours of myocardial infarction) to determine patency of the infarct-related artery (IRA). In the occluded IRA group (n = 35), the incidence of signal-averaged electrocardiographic abnormality (fQRS > 120 ms) was significantly higher (p = 0.04), the filtered QRS duration was significantly longer (p = 0.007), and the V40 was significantly shorter (p = 0.02), compared with the patent IRA group (n = 54).
Publication types
-
Clinical Trial
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Coronary Angiography* / drug effects
-
Death, Sudden, Cardiac / etiology
-
Death, Sudden, Cardiac / prevention & control
-
Electrocardiography* / drug effects
-
Female
-
Humans
-
Male
-
Middle Aged
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / mortality
-
Prospective Studies
-
Recurrence
-
Retrospective Studies
-
Risk Factors
-
Signal Processing, Computer-Assisted*
-
Thrombolytic Therapy*
-
Tissue Plasminogen Activator / therapeutic use*
-
Ventricular Fibrillation / diagnosis
-
Ventricular Fibrillation / drug therapy
-
Ventricular Fibrillation / mortality
Substances
-
Tissue Plasminogen Activator